Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group
Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587)
10/2003
10/21/2003US6635630 Respiratory system disorders; antiinflammatory agents
10/21/2003US6635417 Complex formation between DSDNA and oligomer of cyclic heterocycles
10/21/2003CA2240136C Phenyl-and aminophenyl-alkylsulfonamide and urea derivatives
10/21/2003CA2037100C 6-substituted-hexahydrobenz ¢cd! indoles
10/16/2003WO2003085005A1 Photopolymerizable composition
10/16/2003WO2003084948A1 Nitrogenous heterocyclic compound and medicine thereof
10/16/2003WO2003084940A1 Thiazolidine-4-carbonitriles and analogues and their use as dipeptidyl-peptidas inhibitors
10/16/2003WO2003084932A1 Method for preparing 6-aminomethyl-6,11-dihydro-5h-dibenz[b,e]azepine
10/16/2003WO2003084928A1 Alpha, omega-dicarboximide derivatives as useful uro-selective α1α adrenoceptor blockers
10/16/2003WO2003084533A1 N-`4-(2-imino-pyrrolidin-1-yl)phenyl!-acetamide and corresponding piperidine derivatives as factor xa inhibitors for the treatment of thrombo-embolic diseases
10/16/2003WO2003062171A3 Method for the separation of acids from chemical reaction mixtures by means of ionic fluids
10/16/2003WO2003008407A3 Phenylsulfonyl-1,3-dihydro-2h-indole-2-one derivatives, their preparation and their therapeutic use
10/16/2003WO2002100849A3 Novel nitriles useful as reversible inhibitors of cysteine proteases
10/16/2003WO2001066534A3 Cyclic and bicyclic diamino histamine-3 receptor antagonists
10/16/2003US20030195332 PNA monomer and precursor
10/16/2003US20030195243 Recrystalization of 5-chloro-N-((1S,2R)-3-(3R,4S)-3,4-dihydroxy-1-pyrrolidinyl)-2-hydroxy-3-oxo -1-(phenylmethyl) propyl)-1H-indole-2-carboxamide, for use as hypotensive, hypoglycemic or antiischemic agents
10/16/2003US20030195222 Substituted pyrimidinones and pyrimidinthiones
10/16/2003US20030195211 Inhibitors of human phosphatidylinositol 3-kinase delta
10/16/2003US20030195201 Vanilloid receptor ligands and their use in treatments
10/16/2003US20030195195 Substituted pyridines having antiangiogenic activity
10/16/2003US20030195193 Useful as activated blood coagulation factor X inhibitor; useful as an anticoagulant or an agent for prophylaxis and therapy of diseases caused by thrombus or embolus
10/16/2003US20030195192 Nicotinamides having antiangiogenic activity
10/16/2003US20030195185 For therapy of cough, pain, anxiety, asthma, depression or alcohol abuse
10/16/2003US20030195118 And aryl sulfide derivatives
10/16/2003CA2481995A1 Thiazolidine-4-carbonitriles and analogues and their use as dipeptidyl-peptidas inhibitors
10/16/2003CA2481888A1 Alpha, omega-dicarboximide derivatives as useful uro-selective a1a adrenoceptor blockers
10/16/2003CA2481026A1 N-`4-(2-imino-pyrrolidin-1-yl)phenyl!-acetamide and corresponding piperidine derivatives as factor xa inhibitors for the treatment of thrombo-embolic diseases
10/15/2003EP1352906A1 Compositions for prevention or treatment of hepatopathy
10/15/2003EP1351959A1 Novel pleuromutilin derivatives
10/15/2003EP1351958A1 Imidazolo-5-yl-2-anilino-pyrimidines as agents for the inhibition of the cell proliferation
10/15/2003EP1351956A1 Semicarbazides and their uses as cyclin dependent kinase inhibitors
10/15/2003EP1351950A2 Isoindolyl and isoquinolinyl aroyl pyrrole compounds for the treatment of central nervous system disorders
10/15/2003EP1351934A1 Naphthalene derivatives which bind to the ep4 receptor
10/15/2003EP1351691A1 Substituted 2-aryl-4-arylaminopyrimidines and analogs as activators of caspases and inducers of apoptosis and the use thereof
10/15/2003EP1265873B1 4-oxo-1,4-dihydro-3-cinnolinecarboxamides as antiviral agents
10/15/2003EP1228041B1 Indole derivatives and their use as 5ht2a ligands
10/15/2003EP1135370B1 Carboxylic acids and carboxylic acid isosteres of n-heterocyclic compounds
10/15/2003EP1098890B1 Dihydrotriazolone derivatives as pesticides
10/15/2003EP1051374B1 The use of compressed carbon dioxide in chemical reactions
10/15/2003EP0861246B1 Prolyl endopeptidase inhibitors, their preparation and their pharmaceutical use
10/15/2003EP0763032B1 Palladium catalyzed ring closure of triazolyl tryptamine
10/15/2003CN1449388A Process and intermediates for preparing retroviral protease inhibitors
10/15/2003CN1449386A Nonpeptide substituted spirobenzoazepines as vasopressin antagonists
10/15/2003CN1124267C Dihydropyridazinones and pyridazinones and their use as fungicides and insecticides
10/14/2003US6632828 Substituted imidazole neuropeptide Y Y5 receptor antagonists
10/14/2003US6632825 Picornaviral 3C protease enzyme inhibitors; amide ester or amide acid derivatives
10/14/2003US6632815 Show selectivity for factor Xa versus other proteases of coagulation or the fibrinolytic cascades
10/14/2003US6632813 6-subtituted-7-heteroquinoxalinecarboxylic acid derivatives and addition salts thereof and processes for the preparation of both
10/14/2003US6632810 Cyclic diamine compound with condensed-ring groups
10/14/2003US6632809 Gyrase inhibitors and uses thereof
10/14/2003US6632803 Pharmaceutical formulations containing voriconazole
10/09/2003WO2003082877A1 Piperazine substituted aryl benzodiazepines and their use as dopamine receptor antagonists for the treatment of psychotic disorders
10/09/2003WO2003082860A1 Processes for producing indole compound
10/09/2003WO2003082859A1 Indolylmaleimide derivatives
10/09/2003WO2003082853A1 New compounds
10/09/2003WO2003082831A1 4-anilino quinazoline derivatives as antiproliferative agents
10/09/2003WO2003082829A1 New aryl imidazoles and related compounds as c5a receptor modulators
10/09/2003WO2003082828A1 Substituted tetrahydroisoquinolines as c5a receptor modulators
10/09/2003WO2003082290A1 4-(n-phenylamino)-quinazolines / quinolines as tyrosine kinase inhibitors
10/09/2003WO2003082186A2 Use of benzimidazole analogs in the treatment of cell proliferation
10/09/2003WO2001079189A3 'amides of r-2-(aminoaryl)-propionic acids for use in theprevention of leucocyte activation'
10/09/2003US20030191311 Imidazole derivatives
10/09/2003US20030191308 Quinazoline compounds
10/09/2003US20030191307 2,4-Diaminopyrimidine compounds useful as immunosuppressants
10/09/2003US20030191171 Insecticidal and acaricidal agent
10/09/2003US20030191168 Binding to nucleic acids
10/09/2003US20030191164 Propane-1,3-dione derivatives
10/09/2003US20030191163 Substituted cyclic amine metalloprotease inhibitors
10/09/2003US20030191162 Skin disorders; brain cancer; angiogenesis inhibitor
10/09/2003US20030191156 Antidiabetic agents; dietetics
10/09/2003US20030191155 Triazole derivatives
10/09/2003US20030191143 Attenuation immunology response; antiproliferative agents; rheumatic diseases; hypotensive agents; antilipemic agents; anticholesterol agents
10/09/2003US20030191139 Anticoagulant for mammals
10/09/2003US20030191134 Central nervous system disorders; vision defects; antiproliferative agents
10/09/2003US20030191132 Anticholesterol agents; cardiovascular disorders
10/09/2003US20030191129 Antitumor agents
10/09/2003US20030191128 Anticancer agents; antiproliferative agent
10/09/2003US20030191124 Derivatives of sulphonamides, their preparation and use as medicaments
10/09/2003US20030191116 Gastrin and cholecystokinin receptor ligands (III)
10/09/2003US20030191115 Lactam-containing compounds and derivatives thereof as factor Xa inhibitors
10/09/2003US20030191107 3-(Imidazolyl)-2-aminopropanoic acids
10/09/2003US20030190540 Photoconductive layer containing azo compound; electrostaticlatent image
10/09/2003US20030189191 Fluorescent maleimides and uses thereof
10/09/2003CA2480888A1 New aryl imidazoles and related compounds as c5a receptor modulators
10/09/2003CA2479932A1 Piperazine substituted aryl benzodiazepines and their use as dopamine receptor antagonists for the treatment of psychotic disorders
10/09/2003CA2479930A1 Substituted tetrahydroisoquinolines as c5a receptor modulators
10/09/2003CA2479453A1 Use of benzimidazole analogs in the treatment of cell proliferation
10/08/2003EP1349856A2 Isoindolin-1-one glucokinase activators
10/08/2003EP1349852A2 4-(hetero)aryl substituted indolinones
10/08/2003EP1349841A2 Anilinopyrimidine derivatives as ikk inhibitors and compositions and methods related thereto
10/08/2003EP1349840A2 Anilinopyrimidine derivatives as jnk pathway inhibitors and compositions and methods related thereto
10/08/2003EP1349839A1 Phenylethenyl or phenylethinyl derivatives as glutamate receptor antagonists
10/08/2003EP1349833A1 Indole and dihydroindole derivatives
10/08/2003EP0927170B1 Piperazino derivatives as neurokinin antagonists
10/08/2003CN1447794A Novel compounds
10/08/2003CN1447693A Use of angiotensin Ôàí antagonists
10/08/2003CN1123572C Insoluble s-triazine ferivatives and their use as UV filters
10/08/2003CN1123566C Arylsulfonyl hydroxamic acid derivatives
10/07/2003US6630503 Cell adhesion inhibitors
10/07/2003US6630497 For therapy of hypertension and congestive heart failure; angiotensin II antagonist
1 ... 406 407 408 409 410 411 412 413 414 415 416 417 418 419 420 421 422 423 424 425 426 ... 626